Integrated Biopharma Inc INBP
We take great care to ensure that the data presented and summarized in this overview for INTEGRATED BIOPHARMA INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in INBP
Top Purchases
Top Sells
About INBP
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Insider Transactions at INBP
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 25
2024
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+4.01%
|
$0
$0.09 P/Share
|
Nov 25
2024
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+4.01%
|
$0
$0.09 P/Share
|
Nov 25
2024
|
Dina Masi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+23.45%
|
$0
$0.09 P/Share
|
Sep 20
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.78%
|
$0
$0.09 P/Share
|
Sep 20
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.78%
|
$0
$0.09 P/Share
|
Sep 20
2023
|
Dina Masi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+25.36%
|
$0
$0.09 P/Share
|
May 30
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
50,000
+2.69%
|
$0
$0.34 P/Share
|
May 30
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
50,000
+2.69%
|
$0
$0.34 P/Share
|
May 25
2023
|
Sheppard Riva Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,410,512
+49.89%
|
$0
$0.4 P/Share
|
May 25
2023
|
Christina Kay Co-Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,410,512
+50.0%
|
$0
$0.4 P/Share
|
May 06
2022
|
E Gerald Kay Executive Chairman & President |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+1.84%
|
$0
$0.23 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 176K shares |
---|